chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Exposure to communicable disease, Rash pruritic, Rash vesicular
Clinical narrative: Information has been received from a physician and a consumer concerning her 11-year-old daughter who had a reaction to albuterol and no pertinent medical history who on 26-MAR-1997 at 10:30AM was vaccinated IM with a first dose of Varivax (Lot # 620625/1343D). There was no illness at the time of vaccination. There was no concomitant medication. On 11-JUN-2006 the patient experienced "100-200 lesions" all over her body.  The lesions were fluid filled, but not breaking open and scabbing. No other information was provided. There were no lab diagnostic studies performed. Unspecified medical attention was sought. There was no product quality complaint. The patient's lesions persisted. Follow up information received from a physician indicated that on 12-JUN-2006 at 9:15AM, the physician received a phone call from the mother indicating that the child was exposed to varicella one month prior, and now had red bumps that were itchy. The physician questioned if this was chickenpox, and advised symptomatic treatment. He advised to be seen if concerned. No further information was available. The outcome was unknown. There were no relevant diagnostic tests or laboratory data. There were no adverse events following prior vaccinations of the patient or siblings. The outcome was unknown. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning an 11 year old female who was vaccinated with Varivax (Lot # 622749/0544E). Subsequently the patient experienced full blown varicella rash (more than 50 lesions). It was reported that the patient was not seen by the physician. At the time of the report, the patient was recovering. The physician reported that another patient had developed full blown varicella rash (more than 50 lesions) after being vaccinated with Varivax (WAES# 0606USA01476).
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 9 year old female who was vaccinated with subcutaneous Varivax. On 07-MAR-2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from mild breakthrough varicella. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old male who on 13-JAN-2002, was vaccinated with subcutaneous Varivax. On 23-FEB-2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from mild breakthrough varicella. Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 6 year old male who on 09-FEB-2001, was vaccinated with subcutaneous Varivax. On 20-FEB-2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from mild breakthrough varicella. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old female who on 07-MAR-2001, was vaccinated with subcutaneous Varivax. On 08-FEB-2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from  mild breakthrough varicella. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 6 year old male who on 26-MAY-2000, was vaccinated with subcutaneous Varivax. On 11-JAN_2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from mild breakthrough varicella. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 4 year old male who on 02-MAY-2002 was vaccinated with subcutaneous Varivax. On 10-JAN-2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from mild breakthrough varicella. Additional information has been requested.
Age: 0.9
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 4 year old male who on 27-FEB-2002, was vaccinated with subcutaneous Varivax. On 07-JAN-2006, the patient experienced mild breakthrough varicella. Subsequently, the patient recovered from mild breakthrough varicella. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old male with no known allergies or pertinent medical history who on 24-AUG-2000 was vaccinated IM with a 0.5 ml first dose of Varivax (lot # 634514/0539K). There was no concomitant medication or illness at the time of vaccination. On 30-MAY-2006 the patient developed a breakthrough rash of 15 lesions which started to appear on his abdomen and thighs. The rash began with three, then progressed to 15 "rashes". No fever was reported. Unspecified medical attention was sought. There wee no labs or diagnostic tests performed. On 06-JUN-2006, after one week, the patient recovered. There was no product quality complaint involved. Additional information is not expected.
Age: 1.8
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old female who on 28-FEB-2000 was vaccinated with a dose of Varivax. On 06-JUN-2006 the patient developed breakthrough chickenpox. Medical attention was sought. The patient's outcome was not reported. The patient's vaccination history included: A first, second, third fourth and fifth dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown on 20-JUL-1998, 21-OCT-1998, 12-AUG-1999, 13-NOV-1999, and 03-JUN-2003, respectively; a first, second, and third dose of hepatitis B virus vaccine (unspecified) (manufacturer unknown) on 23-MAY-1998, 20-JUL-1998, and 18-JAN-1999, respectively; a first, second and third dose of Hib vaccine (unspecified) (manufacturer unknown) on 20-JUL-1998, 21-OCT-1998 and 28-FEB-2000, respectively; a first, second, third and fourth dose of poliovirus vaccine inactivated (unspecified) (manufacturer unknown) on 20-JUL-1998, 21-OCT-1998, 12-AUG-1999, and 03-JUN-2003, respectively; and a first and second dose of MMR on 12-AUG-1999 and 03-JUN-2003 respectively. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a licensed practical nurse concerning a 9 year old white female with no known medical history or allergies who on 11-DEC-1997 was vaccinated with a first dose of Varivax. Concomitant vaccination administered that day included a dose of MMR. There was no illness at the time of vaccination. On 07-JUN-2006 the patient developed a chicken pox rash with vesicles. There were less than 50 lesions located on her chin and back. No laboratory diagnostic tests performed. There were no adverse events following prior vaccination. At the time of the report the patient was still recovering. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Pain
Clinical narrative: Information has been received from a physician concerning a 12-year-old female who in June 1995, was vaccinated with one 0.5mL dose of Varivax. The physician reported that in April 2006, the patient presented with a case of shingles. The patient was hospitalized and she needed "pain injections" for a "couple of weeks". A couple of weeks after onset, the patient's shingles resolved. Additional information has been requested.
Age: 1.4
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a health professional concerning a 17 month old male with no known medical history or allergies who on 05-JUN-2006 was vaccinated SC with a 0.5 mL Varivax (lot # 652664/1033R). Suspect vaccination administered on the same day included a 0.5 mL SC dose of MMR (lot # 653317/0211F). "Around" 09-JUN-2006 the patient developed a rash on the face and body. It was reported that the rash had gotten worse. At the time of the report the patient had not recovered. Unspecified medical attention was sought. No laboratory diagnostic tests were performed. It was also mentioned that a rash occurred with other patients. There was no product quality complaint involved. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on 24-OCT-1995 was vaccinated SC with a dose of Varivax. On 04-JUN-2006 the patient developed a breakthrough case of chickenpox. Unspecified medical attention was sought. At the time of the report the patient was recovering. There was no product quality complaint involved. Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 7 year old female who on 16-NOV-1999 was vaccinated with a dose of Varivax. On 11-JUN-2006 the patient developed a breakthrough case of chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 40.0
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative, Incorrect route of drug administration, Injection site vesicles, Malaise, Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 40 year old white male physician's assistant with no pertinent medical history and a penicillin allergy (developed a rash) who on 20-MAY-2006 (also reported as 26-MAY-2006) at 4:30PM, was vaccinated in the right gluteal with a first dose of Varivax (Lot # 646669/0626R). There was no illness at the time of vaccination. There was no concomitant medication. On 09-JUN-2006 (also reported as 11-JUN-2006), 20 days post vaccination, the patient developed a fever which lasted 5 days (also reported as approximately 1 week). He also experienced vesicles at the injection site. During this time period, he also developed lesions, about 10 lesions each day up to 40 lesions total. The physician made a house call to the patient and diagnosed him with a full-blown case of chickenpox. The patient missed 1 week and 1 day of work. The outcome was reported as recovered. The exact date of recovery was unknown, but the patient returned to work on 19-JUN-2006. It was noted that antibodies taken before vaccination showed no immunity. There was no product quality complaint. Follow up information received from a registered nurse indicated that on 11-JUN-2006, the patient developed a vesicular rash which was preceded by malaise and subjective fevers for approximately 1 week. The patient recovered on approximately 17-JUN-2006. There were no diagnostic tests or laboratory data. There were no adverse events following prior vaccinations. Chickenpox was considered to be disabling. No additional information is expected.
Age: 40.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular, Skin lesion, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 40 year old white male physician's assistant with no pertinent medical history and a penicillin allergy (developed a rash) who on 20-MAY-2006 (also reported as 26-MAY-2006) at 4:30PM, was vaccinated in the right gluteal with a first dose of Varivax (Lot # 646669/0626R). There was no illness at the time of vaccination. There was no concomitant medication. On 09-JUN-2006 (also reported as 11-JUN-2006), 20 days post vaccination, the patient developed a fever which lasted 5 days (also reported as approximately 1 week). He also experienced vesicles at the injection site. During this time period, he also developed lesions, about 10 lesions each day up to 40 lesions total. The physician made a house call to the patient and diagnosed him with a full-blown case of chickenpox. The patient missed 1 week and 1 day of work. The outcome was reported as recovered. The exact date of recovery was unknown, but the patient returned to work on 19-JUN-2006. It was noted that antibodies taken before vaccination showed no immunity. There was no product quality complaint. Follow up information received from a registered nurse indicated that on 11-JUN-2006, the patient developed a vesicular rash which was preceded by malaise and subjective fevers for approximately 1 week. The patient recovered on approximately 17-JUN-2006. There were no diagnostic tests or laboratory data. There were no adverse events following prior vaccinations. Chickenpox was considered to be disabling. No additional information is expected.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Herpes zoster, Rash
Clinical narrative: Information has been received from a physician concerning a 7-year-old white female with no pre-existing allergies, birth defects, or medical conditions who on 01-MAY-2000 was vaccinated IM in the right leg with first dose of Varivax (Lot # 632049/1365J). There was no illness at the time of vaccination. On 31-MAY-2006, the mother brought the child to the physician for what she thought was a rash of poison ivy over her left leg which started about 72 hours prior to the visit. The mother was treating the rash with calamine lotion and TYLENOL for discomfort. The physician diagnosed the patient with clinical zoster. Vesicles were noted on the left buttocks and anterior left upper leg. There was a 50-cent sized patch of erythema with some slight vesiculation over the high buttocks stopping at the midline. There was a larger patch, perhaps 8x6-cm over the anterior left thigh, which contained some coalesced vesicles and then a few scattered vesicles down over the lower leg anteriorly. The patient walked well. There was no motor deficit. The remainder of the skin was clear. She was afebrile, alert, interactive, and nontoxic. No significant inguinal lymphadenopathy was noted. The physician provided the mother with mimix and adaptic dressing to put on the zoster. Subsequently the patient recovered from clinical zoster. There were no relevant diagnostic tests or laboratory data. No additional information is expected.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning an 11 year old female with a history of a "reaction" to AMOXIL, who on 12-FEB-1997 was vaccinated with a dose of Varivax. On 20-JUN-2006 the patient developed chicken pox and had "20-25 lesions) on her neck, shoulders, chest and legs. No fever or itching was noted. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information from the registered nurse indicated that the patient had recovered. No additional information was available. The vaccination was not given at that office. No further information is expected.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature increased, Headache, Myalgia, Pruritus, Pyrexia
Clinical narrative: Information has been received from an employee in a physician's office concerning an 8 year old female who on 01-OCT-1999 was vaccinated SC in the left arm with a first dose of Varivax (lot # 631303/0726J). There was no illness at the time of vaccination. The mother called the office reporting symptoms of fever, headache, muscle aches, and "spots" on the body that started on 17-JUN-2006. The patient had a fever of 102 to 103 for two days. The rash was described as scattered fluid-filled lesions, some of which were crusted. The patient complained of itching. The patient was exposed to varicella at the end of May 2006. The patient was examined in the office and was found to have 75 to 100 lesions on the scalp, face, back, chest, and legs. The mother noted that the rash started on 15-JUN-2006. No diagnostic laboratory tests were performed. A supportive treatment plan was noted. Additional information is not expected.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from an employee in a physician's office concerning an 8 year old female who on 01-OCT-1999 was vaccinated SC in the left arm with a first dose of Varivax (lot # 631303/0726J). There was no illness at the time of vaccination. The mother called the office reporting symptoms of fever, headache, muscle aches, and "spots" on the body that started on 17-JUN-2006. The patient had a fever of 102 to 103 for two days. The rash was described as scattered fluid-filled lesions, some of which were crusted. The patient complained of itching. The patient was exposed to varicella at the end of May 2006. The patient was examined in the office and was found to have 75 to 100 lesions on the scalp, face, back, chest, and legs. The mother noted that the rash started on 15-JUN-2006. No diagnostic laboratory tests were performed. A supportive treatment plan was noted. Additional information is not expected.
Age: 1.3
Sex: F
Vaccine: HIBV, VARCEL
Symptoms: Rash papular
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old white female with no allergies or medical conditions who on 14-MAY-2002 was vaccinated SC in the left arm with a first dose of Varivax (lot # 638367/0198M). Concomitant vaccination on the same day included an IM fourth dose in the left arm of HIBTITER (lot # 480-695). Illness at the time of vaccination included allergic rhinitis. On 02-JUN-2006, in the p.m., the patient developed small papular lesions scattered on the abdomen. Some were crusted. The patient was seen at the doctor's office and treated with BENADRYL and AVEENO baths. No diagnostic laboratory tests were performed. The patient recovered on an unspecified date. It was noted that the patient had no adverse events following prior vaccination. Additional information is not expected.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 44 month old female who on 04-DEC-2003 was vaccinated subcutaneously in the right arm (also reported as the left outer arm) with a 0.5 ml first dose of Varivax (lot # 646138/0475N). On 05-JUN-2006 the patient developed a mild case of breakthrough chicken pox. The patient had less than 50 lesions. At the time of examination the patient had 12 lesions on her face only. There was no treatment or other symptoms noted. There was no product quality complaint involved. No further information is available.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Ear infection, Pyrexia, Varicella
Clinical narrative: Information has been received from a health professional concerning a 36 month old female who in approximately April 2004 (also reported as 03-APR-2003), was vaccinated subcutaneously with a 0.5 ml dose of Varivax (lot # 647259/1137N). On 24-APR-2006 the patient developed a chicken pox rash which was mostly on her abdomen and left palm. Patient was also noted to have an external ear infection with fever at the same time. Subsequently, the patient recovered from chicken pox. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Rash vesicular
Clinical narrative: Information has been received from a health professional concerning a 29 month old male who on 05-NOV-2004 was vaccinated subcutaneously with a 0.5 ml dose of Varivax (lot # 648302/0187P). On 03-APR-2006 the patient developed a vesicular rash and presented to the practice with the vesicular rash of about 100 itchy lesions. No other symptoms were noted. Subsequently the patient recovered. There was no product quality complaint involved. No additional information is available.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received concerning an 8 year old white female with an allergy to SEPTRA who on 29-JUL-1998 was vaccinated with a SC dose of Varivax (lot # 626956/0837H). Suspect vaccination administered that day included a SC dose of MMR (lot # 627842/0798H). There was no illness at the time of vaccination. On 06-JUN-2006 the patient developed a rash. Medical attention was sought and no laboratory tests were performed. The patient's outcome was recovered on 06-JUN-2006. It was reported that the patient's brother (WAES# 0606USA04668) had as similar experience after vaccination with Varivax. Additional information is not expected.
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received concerning a white female with no known allergies who on 20-JUL-2001 was vaccinated SC with Varivax (639128/0567L). Suspect vaccination that day included a SC dose of MMR (lot # 639618/0736L). There was no illness at the time of vaccination. On 07-JUN-2006 the patient developed a rash. Medical attention was not sought and no laboratory diagnostic tests were performed. The patient's outcome was recovered on 07-JUN-2006. It was reported that the patient's sister (WAES# 0606USA04662) had a similar experience after vaccination with Varivax. Additional information is not expected.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Skin lesion, Varicella
Clinical narrative: Information has been received from a medical assistant concerning a 6 year old white male with no known medical history who on 05-APR-2001 was vaccinated with a first dose of Varivax (lot # 636575/1467K). There was no illness at the time of vaccination. On 31-MAY-2006 the patient developed a rash all over for 1 day, "a few more on chest in the morning of 31-MAY-2006 and had doubled in number". It was reported that the neighbor has possible chickenpox five days prior. The patient was seen for a doctor's visit, 125-150 lesions were noted and he was diagnosed with chickenpox. The patient was treated with BENADRYL prn and Aveeno bath. Subsequently he recovered. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning a 5 year old male with seasonal allergies, and no other medical history, who on 17-OCT-2001 was vaccinated SC in the left leg with a 0.5 ml first dose of Varivax (lot # 638813/0239L). There was no concomitant medication. On 24-JUN-2006 the patient experienced over 40 lesions. The patient sought unspecified medical attention. At the time of the report the patient had not recovered. No product quality complaint was involved. Follow up information indicated that on 22-Jun-2006 the patient developed 40 lesions. The patient was seen for a doctor's visit. No further information was provided. No other information is expected.
Age: 1.3
Sex: U
Vaccine: VARCEL
Symptoms: Varicella, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a physician concerning a 4-year-patient who on 25-OCT-2002 was vaccinated with a dose of Varivax (Lot # 640153/0823L). On 11-MAY-2006 the patient developed a breakthrough of chickenpox. The patient tested seropositive on 15-MAY-2006. The office scraped some of the patient's lesions and sent them to a lab which confirmed it was a wild-type strain chickenpox and not vaccine-type strain. There was no product quality complaint. Follow up information indicated that the aunt of the patient contracted varicella. No additional information is expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently," in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently," in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently" in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experienced was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that he child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experienced was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. it was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an a unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Excoriation, Varicella
Clinical narrative: Information has been received from a woman working in a physician's office concerning a child who was vaccinated with a dose of Varivax. "Very recently", in 2006, the patient experienced breakthrough chickenpox. It was reported that the child was being boostered. It was also noted that the child was in an a unspecified stage of breaking out with lesions. It was reported that the patient's experience was currently ongoing. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that he was aware of the breakthrough of chickenpox at the local school, but had "no idea" about any additional information. Additional information is not expected.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 7 year old white male with no known allergies or past medical history who on 10-FEB-2000 was vaccinated SC with a 0.5 ml first dose of Varivax (lot# "1305J-M"). There was no concomitant medication. On 26-JUN-2006 the patient experienced a "breakthrough rash of 50 or more lesions" of chicken pox. Unspecified medical attention was sought. On 11-JUL-2006 the patient recovered. There was no product quality complaint involved. Additional information is not expected.
Age: 50.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Information has been received from a physician concerning a 50 year old white female employee with no known allergies or past medical history who on 25-JUN-2006 was vaccinated in the left deltoid with a first dose of Varivax. There was no illness at the time of vaccination. Subsequently the patient developed 3-4 vesicular lesions at the injection site. At the time of the report the lesions persisted. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information received from the physician indicated that the patient recovered on 29-JUN-2006. No additional information is expected.
Age: 47.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a 47 year old female registered nurse who in 2002 was vaccinated subcutaneously with two doses of Varivax. Subsequently the patient's titer in 2002 was 0.86, normal was reported to be above 0.9. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 4-5 year old patient, who was vaccinated with a dose of Varivax. "Within the past 2 weeks", in April or May 2006, the patient experienced mild breakthrough. Unspecified medical attention as sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 4-5 year old patient who was vaccinated with a dose of Varivax. "Within the past 2 weeks," in April or May 2006, the patient experienced mild breakthrough. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Information has been received from a physician concerning a 32 month old female who in October 2004 was vaccinated with a dose of Varivax. Subsequently the patient experienced breakthrough varicella rash. It was reported that the patient had not recovered. Unspecified medical attention was sought. No further information available. There was no product quality complaint involved. Additional information received indicated that there was no further information available. No additional information is expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 10-year-old female with no known drug allergies, who on 04-APR-1997 was vaccinated subcutaneously in the RAT with a dose of Varivax. Subsequently, on 23-JUN-2006, the patient developed chickenpox with multiple lesions on her trunk. The outcome was unknown. Additional information has been requested.
Age: 11.0
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 16 year old patient who on 02-AUG-2001 was vaccinated with a SC dose of Varivax (lot # "18897"). On 27-JUN-2006 the patient developed shingles. Unspecified medical attention was sought. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning a coworker who in "possibly" 1999 was vaccinated with a first and second dose of Varivax. In "possibly" 2003 the patient had a titer taken that was "low". There was no product quality complaint involved. Additional information has been requested.
Age: 25.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning male "in his 20's" with no pertinent medical history and no drug reactions/allergies who on 30-JUN-2005 was vaccinated with a dose of Varivax. There was no concomitant medication. On 02-JUL-2006, two days later, the patient developed chickenpox. He had lesions from head to toe. The physician had not yet seen the patient at the time of the report. The patient's chickenpox persisted. Unspecified medical attention was sought. There were no lab diagnostic studies performed. There were no other details to report. There was no product quality complaint. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning a male with no medical history (allergies unknown) who was vaccinated as a child (age unspecified) with a dose Varivax. There was no concomitant medication. Subsequently the patient's varicella titer result was negative. It was reported that the patient never got sick from chickenpox. Medical attention was sought. There was no product quality complaint involved. Follow-up information from the registered nurse indicated that it was unclear as to whether or not the patient had one or two previous vaccinations. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: HEP, VARCEL
Symptoms: Rash papular, Rash vesicular
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 7-year-old white male with no pre-existing allergies, birth defects or medical conditions, who on 07-JUN-1999 was vaccinated in the left arm with a first dose of Varivax (lot# 630027/0312J). Concomitant vaccination given on the same day included a third dose of ENGERIX-B (lot# 2937A2) given in the left arm. There was no illness at the time of vaccination. On 22-APR-2006 the patient experienced multiple vesicles and papules on his abdomen, back and foot. Unspecified medical attention was sought. No treatment was provided other than comfort measures. No laboratory or diagnostic tests were performed. It was noted that at the time of the report the patient had recovered. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician and a registered nurse (RN) concerning a 16-month-old female with no known drug allergies, who on 24-FEB-2006 at 14:00 was vaccinated subcutaneously in the left arm with a first dose of Varivax (lot# 650388/0914R). On 22-JUN-2006 the patient developed lesions, on 23-JUN-2006 she was seen in the physician's office and was diagnosed with chickenpox (mild, < 50 lesions). The patient was seen back in the physician's office on 07-JUL-2006 and was recovered. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 12-month-old female who on 04-MAY-2006 was vaccinated with a dose of Varivax (lot# 652804/0263F). Concomitant vaccination included a dose of MMR. Subsequently, on an unspecified date, the patient developed a minimum of 50 pock marks, sought unspecified medical attention and was diagnosed with chickenpox. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 12-month-old male who on 04-MAY-2006 was vaccinated with a dose of Varivax (lot# 652804/0263F). There was no concomitant vaccinations. Subsequently, on an unspecified date, the patient developed a minimum of 50 pock marks, sought unspecified medical attention and was diagnosed with chickenpox. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Secondary transmission, Varicella
Clinical narrative: Information has been received from a Registered Nurse concerning a 21 month old male who on 09-SEP-2005 was vaccinated subcutaneously with a 0.5 ml dose of Varivax. On 05-Jul-2006 it was reported that "last week" in June 2006 the patient had a breakthrough experience. The nurse reported that the patient was playing with another child who had chickenpox and he started developing lesions "shortly after". The patient had less than 50 lesions. Unspecified medical attention was sought and the pt recovered with an unspecified "therapy". There was no product quality complaint involved. Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Rash pustular, Rash vesicular, Scab, Varicella
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old female with no known medical history or allergies who on 12-SEP-2003 was vaccinated SC with Varivax (lot # 644796/0336N). Concomitant therapy included melatonin. On 03-JUL-2006 the patient presented with breakthrough chickenpox. The patient had approximately 60 pus marks in different stages. Some of the rashes consisted of small red bumps, some were fluid filled, and some were scabbed over. The rashes were very itchy. The patient was afebrile. It was reported that the patient was exposed on 28-JUN-2006 to an older sibling who had shingles. Medical attention was sought. No laboratory diagnostic tests were performed. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a healthcare worker concerning a 4 year old female with no allergies or medical history who on 25-OCT-2002 was vaccinated with a dose of Varivax. There was no concomitant medication. On 04-JUL-2006, the patient developed red, raised bumps diagnosed as chickenpox. Unspecified medical attention was sought and no treatment was required. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.
Age: 1.4
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Information has been received from a medical assistant concerning a 6-year-old male with no medical history or no known allergies who on 23-MAR-2001 was vaccinated with a dose of Varivax. There was no concomitant therapy. The medical assistant reported that on 01-JUL-2006 (also reported as 05-JUL-2006), the patient developed a red itchy rash. Unspecified medical attention was sought and BENADRYL was recommended. No laboratory/diagnostic tests were performed. At the time of this report, the patient's red itchy rash persisted. The medical assistant also reported that the patient's sibling experienced an adverse event after being vaccinated with Varivax (WAES #0609USA03175). Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old male who on 04-Sep-2001, was vaccinated with a dose of Varivax. Subsequently, on 17-May-2006 the patient experienced breakthrough varicella rash. Unspecified medical attention was sought. No further information available. There was no product quality complaint involved. Additional information received indicated that there was no further information available. No additional information is expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 9 year old male who on 26-Jan-1998, was vaccinated with a dose of Varivax. Subsequently, on 16-May-2006 the patient experienced a "mild" case of breakthrough varicella rash. Unspecified medical attention was sought. No further information available. There was no product quality complaint involved. Additional information received indicated that there was no further information available. No additional information is expected.
Age: 1.3
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Information has been received from a physician concerning a 6 year old male who on 15-JUN-2001 was vaccinated with a dose of Varivax. Subsequently, on 16-APR-2006 the patient experienced a "mild" case of breakthrough varicella rash. Unspecified medical attention was sought. No further information available. There was no product quality complaint involved. Additional information received that there was no further information available. No additional information is expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 7 year old female who on 04-FEB-2000 was vaccinated with a dose of Varivax. Subsequently on 05-APR-2006 the patient experienced breakthrough varicella rash. Unspecified medical attention was sought. No further information available. There was no product quality complaint involved. Additional information received indicated that there was no further information available. No additional information is expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Information has been received from a physician concerning an 8 year old male who on 21-Aug-1998 was vaccinated with a dose of Varivax. Subsequently on 24-Apr-2006 the patient experienced a "mild" case of breakthrough varicella rash. Unspecified medical attention was sought. No further information is available. There was no product quality complaint involved. Additional information received indicated that there was no further information available. No additional information is expected.
Age: 31.0
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a physician's assistant concerning a 31 year old male who in 2003 was vaccianted with a dose of varicella virus vaccine live. On 27-JUN-2006 the patient's titer result was subtheraputic. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.